Their findings suggest that CircNFIB may function as a natural suppressor of tumor progression in iCCA by directly binding to MEK1 and preventing its interaction with ERK1/2, thereby inhibiting activation of the ERK1/2 signaling pathway [95]. Here, MAP2K1 is linked to neoplasm.